The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,851,337 in first-year total cost, median $445,000.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-N (O1)]8
- Special Emphasis Panel[ZHL1 CSR-Q (O1)]1
Most frequent institutions
- CHILDREN'S HOSP OF PHILADELPHIA3
- JOHNS HOPKINS UNIVERSITY2
- BLOODWORKS1
- BRIGHAM AND WOMEN'S HOSPITAL1
- EMORY UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Inflammation-associated Autophagy Dysfunction1R00HL177831-01 | DAVIZON-CASTILLO, PAVEL | BLOODWORKS, WA | $465,000 | ZHL1 |
| 2025 | Defining the Role of Platelet ABO(H) Blood Group Antigens in Hemostasis and Thrombosis1R00HL177820-01 | HOLLENHORST, MARIE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $445,708 | ZHL1 |
| 2025 | Determining genetic mechanisms that drive in vitro hematopoiesis1R00HL177827-01 | THOM, CHRISTOPHER STEPHEN | CHILDREN'S HOSP OF PHILADELPHIA, PA | $445,000 | ZHL1 |
| 2025 | Mechanisms of Impaired Granulopoiesis Due to CLPB Mutations1R00HL177828-01 | WARREN, JULIA THERESE | CHILDREN'S HOSP OF PHILADELPHIA, PA | $445,000 | ZHL1 |
| 2025 | NET stabilization: mechanistic and therapeutic studies studying the role of NETs in thromboinflammatory disease1R00HL177830-01 | GOLLOMP, KANDACE | CHILDREN'S HOSP OF PHILADELPHIA, PA | $445,000 | ZHL1 |
| 2025 | Defining the Innate Immune Cell Profile of Factor VIII Immunity1R00HL177822-01 | BATSULI, GLAIVY | STANFORD UNIVERSITY, CA | $395,314 | ZHL1 |
| 2025 | Investigating fibrinogen as a pathologic and targetable mediator of COVID-19-associated coagulopathy1R00HL177821-01 | MAIER, CHERYL | EMORY UNIVERSITY, GA | $391,250 | ZHL1 |
| 2025 | Protection of hematopoietic stem progenitor cells from endogenous DNA damage1R00HL177829-01 | JUNG, MOONJUNG | JOHNS HOPKINS UNIVERSITY, MD | $380,383 | ZHL1 |
| 2024 | Targeting silent cerebral infarction to improve long-term neurologic outcomes in immune thrombotic thrombocytopenic purpura (iTTP)1R00HL172303-01 | CHATURVEDI, SHRUTI | JOHNS HOPKINS UNIVERSITY, MD | $438,682 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.